title: EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry.
abstract: BACKGROUND
  The level of administered activity in radionuclide therapy is often limited by haematological toxicity resulting from the absorbed dose delivered to the bone marrow. The purpose of these EANM guidelines is to provide advice to scientists and clinicians on data acquisition and data analysis related to bone-marrow and whole-body dosimetry.
  
  
  METHODS
  The guidelines are divided into sections "Data acquisition" and "Data analysis". The Data acquisition section provides advice on the measurements required for accurate dosimetry including blood samples, quantitative imaging and/or whole-body measurements with a single probe. Issues specific to given radiopharmaceuticals are considered. The Data analysis section provides advice on the calculation of absorbed doses to the whole body and the bone marrow. The total absorbed dose to the bone marrow consists of contributions from activity in the bone marrow itself (self-absorbed dose) and the cross-absorbed dose to the bone marrow from activity in bone, larger organs and the remainder of the body.
  
  
  CONCLUSIONS
  As radionuclide therapy enters an era where patient-specific dosimetry is used to guide treatments, accurate bone-marrow and whole-body dosimetry will become an essential element of treatment planning. We hope that these guidelines will provide a basis for the optimization and standardization of the treatment of cancer with radiopharmaceuticals, which will facilitate single- and multi-centre radionuclide therapy studies.
authors.affiliation: Imagerie Médicale, ONIRIS - Ecole Nationale Vétérinaire, Agroalimentaire et d'Alimentation Nantes Atlantique, Atlanpole, La Chantrerie, BP 40706, 44307 CEDEX 3, Nantes, France, cecilia.hindorf@oniris-nantes.fr
authors.forename: Cecilia
authors.initials: C
authors.lastname: Hindorf
authors.forename: Gerhard
authors.initials: G
authors.lastname: Glatting
authors.forename: Carlo
authors.initials: C
authors.lastname: Chiesa
authors.forename: Ola
authors.initials: O
authors.lastname: Lindén
authors.forename: Glenn
authors.initials: G
authors.lastname: Flux
mesh_terms: D001773:Blood Cells / Q000528:radiation effects; D001853:Bone Marrow / Q000000981:diagnostic imaging / Q000473:pathology / Q000528:radiation effects*; D005060:Europe; D005110:Extracellular Space / Q000528:radiation effects; D007091:Image Processing, Computer-Assisted; D009683:Nuclear Medicine / Q000379:methods*; D011829:Radiation Dosage; D011859:Radiography; D011874:Radiometry / Q000379:methods*; D011877:Radionuclide Imaging; D012955:Societies, Medical; D013997:Time Factors; D051598:Whole Body Imaging / Q000379:methods*
references.citation: Cancer Biother Radiopharm. 2003 Apr;18(2):209-15
references.pmid: 12804046
references.citation: Med Phys. 1991 May-Jun;18(3):533-41
references.pmid: 1870497
references.citation: J Nucl Med. 1993 Apr;34(4):689-94
references.pmid: 8455089
references.citation: J Nucl Med. 2003 Jan;44(1):67-76
references.pmid: 12515878
references.citation: Cancer. 2002 Feb 15;94(4 Suppl):1235-9
references.pmid: 11877751
references.citation: J Nucl Med. 1999 Dec;40(12):2102-6
references.pmid: 10616892
references.citation: J Nucl Med. 2004 Aug;45(8):1366-72
references.pmid: 15299063
references.citation: J Nucl Med. 1998 Aug;39(8 Suppl):21S-27S
references.pmid: 9708567
references.citation: J Nucl Med. 2004 Oct;45(10):1725-33
references.pmid: 15471841
references.citation: J Nucl Med. 1998 Oct;39(10):1746-51
references.pmid: 9776281
references.citation: J Nucl Med. 1999 Feb;40(2):37S-61S
references.pmid: 10025848
references.citation: Phys Med Biol. 1976 Jan;21(1):16-38
references.pmid: 1257296
references.citation: Phys Med Biol. 1981 May;26(3):389-400
references.pmid: 7243876
references.citation: Med Phys. 2002 Jun;29(6):1054-70
references.pmid: 12094975
references.citation: Phys Med Biol. 1976 Jul;21(4):589-607
references.pmid: 972924
references.citation: Int J Radiat Biol. 2001 Jun;77(6):703-12
references.pmid: 11403710
references.citation: J Nucl Med. 2000 Sep;41(9):1579-86
references.pmid: 10994741
references.citation: Br J Haematol. 2003 Mar;120(5):853-9
references.pmid: 12614222
references.citation: Cancer Biother Radiopharm. 2002 Aug;17(4):405-26
references.pmid: 12396705
references.citation: Med Phys. 1976 Jul-Aug;03(04):253-5
references.pmid: 958163
references.citation: Phys Med Biol. 1977 Mar;22(2):298-308
references.pmid: 857264
references.citation: J Nucl Med. 2000 Jan;41(1):189-212
references.pmid: 10647623
references.citation: J Nucl Med. 2007 Nov;48(11):1880-8
references.pmid: 17942808
references.citation: Cancer Biother Radiopharm. 2002 Aug;17(4):445-64
references.pmid: 12396708
references.citation: J Nucl Med. 1996 Mar;37(3):538-46
references.pmid: 8772664
references.citation: Cancer Biother Radiopharm. 2002 Aug;17(4):435-43
references.pmid: 12396707
references.citation: Cancer Biother Radiopharm. 2006 Aug;21(4):352-63
references.pmid: 16999601
references.citation: J Nucl Med. 1996 Apr;37(4):695-8
references.pmid: 8691269
references.citation: J Nucl Med. 2002 Sep;43(9):1245-53
references.pmid: 12215566
references.citation: J Nucl Med. 2007 Apr;48(4):645-54
references.pmid: 17401104
references.citation: IEEE Trans Med Imaging. 1991;10(3):408-12
references.pmid: 18222843
references.citation: J Comput Assist Tomogr. 1984 Apr;8(2):306-16
references.pmid: 6608535
references.citation: J Nucl Med. 2005 Jul;46(7):1171-85
references.pmid: 16000287
references.citation: Int J Rad Appl Instrum B. 1989;16(6):553-9
references.pmid: 2481657
references.citation: Med Phys. 2000 Sep;27(9):2150-64
references.pmid: 11011745
references.citation: Phys Med Biol. 1979 Jan;24(1):176-80
references.pmid: 372956
references.citation: Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1337-45
references.pmid: 16832633
references.citation: J Nucl Med. 2005 Jun;46(6):1023-7
references.pmid: 15937315
references.citation: Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1138-46
references.pmid: 19247653
references.citation: Cancer. 2000 Jan 15;88(2):333-43
references.pmid: 10640965
references.citation: Health Phys. 2003 Sep;85(3):294-310
references.pmid: 12938720
references.citation: Health Phys. 2000 Feb;78(2):199-214
references.pmid: 10647986
references.citation: J Nucl Med. 2009 Nov;50(11):1844-7
references.pmid: 19837771
references.citation: J Nucl Med. 2001 Nov;42(11):1713-21
references.pmid: 11696644
references.citation: J Nucl Med. 2009 Feb;50(2):316-23
references.pmid: 19164237
references.citation: J Nucl Med. 1999 Nov;40(11):1947-66
references.pmid: 10565793
references.citation: J Nucl Med. 1999 Dec;40(12):2115-24
references.pmid: 10616894
references.citation: J Nucl Med. 2005 Feb;46(2):344-53
references.pmid: 15695796
references.citation: IEEE Trans Med Imaging. 2008 Apr;27(4):521-30
references.pmid: 18390348
references.citation: Acta Oncol. 2005;44(6):579-88
references.pmid: 16165917
references.citation: J Nucl Med. 2006 Oct;47(10):1592-8
references.pmid: 17015893
references.citation: Phys Med Biol. 2007 Sep 7;52(17):5231-48
references.pmid: 17762083
references.citation: Eur Radiol. 2007 Mar;17(3):743-61
references.pmid: 17021706
references.citation: Med Phys. 1995 Oct;22(10):1637-43
references.pmid: 8551988
references.citation: J Nucl Med. 2009 Mar;50(3):477-84
references.pmid: 19258258
references.citation: J Nucl Med. 2009 Sep;50(9):1518-24
references.pmid: 19713562
references.citation: J Nucl Med. 2005 May;46(5):899-900; author reply 901
references.pmid: 15872367
references.citation: Med Phys. 2007 Nov;34(11):4285-92
references.pmid: 18072493
references.citation: J Nucl Med. 2006 Nov;47(11):1875-83
references.pmid: 17079822
references.citation: IEEE Trans Med Imaging. 1982;1(2):113-22
references.pmid: 18238264
references.citation: Cancer Biother Radiopharm. 2002 Oct;17(5):535-43
references.pmid: 12470423
references.citation: Cancer Biother Radiopharm. 2002 Aug;17(4):427-33
references.pmid: 12396706
references.citation: Cancer Biother Radiopharm. 2007 Apr;22(2):243-9
references.pmid: 17600471
references.citation: Radiat Prot Dosimetry. 2007;127(1-4):192-6
references.pmid: 17569687
references.citation: J Nucl Med Technol. 2002 Sep;30(3):109-14
references.pmid: 12186959
references.citation: Ann ICRP. 1995;25(2):1-80
references.pmid: 8659813
references.citation: Acta Oncol. 2002;41(3):297-303
references.pmid: 12195750